Skip to content
healthcare.dev

Coreg CR

NDC 80725-387, Carvedilol Phosphate, capsule, extended release, from Waylis Therapeutics LLC.

Product NDC
80725-387
Status
Listed
Labeler
Waylis Therapeutics LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80725-387 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARVEDILOL PHOSPHATE40 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; Adrenergic beta1-Antagonists [MoA]; Adrenergic beta2-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
80725-387-138072503871330 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80725-387-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d3625d78-6eb6-41fe-8f6f-664965c104c4

Use it

Look up 80725-387 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80725-387 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80725-387. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.